BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2643666)

  • 1. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1989 Feb; 142(3):959-65. PubMed ID: 2643666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of soluble yeast beta-glucans that inhibit human monocyte phagocytosis mediated by beta-glucan receptors.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1986 Nov; 137(10):3270-6. PubMed ID: 3021849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors.
    Czop JK; Valiante NM; Janusz MJ
    Prog Clin Biol Res; 1989; 297():287-96. PubMed ID: 2555820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and isolation of rabbit anti-idiotypic antibodies directed against the human monocyte receptor for yeast beta-glucans.
    Czop JK; Gurish MF; Kadish JL
    J Immunol; 1990 Aug; 145(3):995-1001. PubMed ID: 1695652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbation of beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene B4 production.
    Czop JK; Puglisi AV; Miorandi DZ; Austen KF
    J Immunol; 1988 Nov; 141(9):3170-6. PubMed ID: 2844908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway.
    Czop JK; Austen KF
    J Immunol; 1985 Apr; 134(4):2588-93. PubMed ID: 2579146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal enzyme release from human monocytes by particulate activators is mediated by beta-glucan inhibitable receptors.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1987 Jun; 138(11):3897-901. PubMed ID: 3035014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte beta-glucan receptors.
    Janusz MJ; Austen KF; Czop JK
    Immunology; 1988 Oct; 65(2):181-5. PubMed ID: 2847978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators.
    Williams JD; Czop JK; Austen KF
    J Immunol; 1984 Jun; 132(6):3034-40. PubMed ID: 6327815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis of unopsonized zymosan particles by trypsin-sensitive and beta-glucan-inhibitable receptors on bone marrow-derived murine macrophages.
    Kadish JL; Choi CC; Czop JK
    Immunol Res; 1986; 5(2):129-38. PubMed ID: 3020136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of membrane complement receptor type three (CR3) for beta-glucans.
    Ross GD; Cain JA; Myones BL; Newman SL; Lachmann PJ
    Complement; 1987; 4(2):61-74. PubMed ID: 3040332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis.
    Czop JK; Austen KF
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2751-5. PubMed ID: 2986134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes.
    Elstad MR; Parker CJ; Cowley FS; Wilcox LA; McIntyre TM; Prescott SM; Zimmerman GA
    J Immunol; 1994 Jan; 152(1):220-30. PubMed ID: 7902855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis of serum-opsonized zymosan down-regulates the expression of CR3 and FcRI in the membrane of human monocytes.
    Wolf HM; Mannhalter JW; Salzmann HC; Göttlicher J; Ahmad R; Eibl MM
    J Immunol; 1988 Nov; 141(10):3537-43. PubMed ID: 2972775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a beta-1,3-D-glucan receptor in P388D1 cells treated with retinoic acid or 1,25-dihydroxyvitamin D3.
    Goldman R
    Immunology; 1988 Feb; 63(2):319-24. PubMed ID: 2832311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the beta-glucan receptor of murine macrophages.
    Goldman R
    Exp Cell Res; 1988 Feb; 174(2):481-90. PubMed ID: 2828085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminarin, a soluble beta-glucan, inhibits macrophage phagocytosis of zymosan but has no effect on lipopolysaccharide mediated augmentation of phagocytosis.
    Fuentes AL; Millis L; Sigola LB
    Int Immunopharmacol; 2011 Nov; 11(11):1939-45. PubMed ID: 21856445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
    Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
    J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan.
    Williams JD; Topley N; Alobaidi HM; Harber MJ
    Immunology; 1986 May; 58(1):117-24. PubMed ID: 3710519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.